better for weight loss semaglutide or tirzepatide GLP-1 Vs Zepbound Tirzepatide GLP-1 medication may be

The FLOW kidney outcomes trial showed a 24% reduction in adverse kidney events

Trulicity and Ozempic are popular GLP-1 receptor agonists FDA-approved to treat type 2 diabetes and lower the risk of serious cardiovascular problems in certain people with existing heart disease or risk factors for heart disease

People who lose muscle during weight loss are more likely to regain weight afterward because their metabolism has slowed and their body composition has worsened

Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation

If the same 10 mg vial is reconstituted with 2.5 mL the concentration doubles to 4 mg/mL and the mL values halve: 250 g becomes 0.0625 mL, which is hard to draw accurately on a U-100 syringe

Food choices matter